An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL)

NCT01276405 · clinicaltrials.gov ↗
TERMINATED
Status
123
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche